Perioperative Medicine for the Hospitalized Patient

Medical Clinics of North America

Volumn 92, Issue 2, 2008, Pages 325-348

  Grant, Paul J ^a   Wesorick, David H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY STENT; FUNCTIONAL STATUS; GLYCEMIC CONTROL; HEART DISEASE; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; LOW DRUG DOSE; LUNG DISEASE; LUNG EXAMINATION; MORBIDITY; MORTALITY; PATIENT CARE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; REVASCULARIZATION; REVIEW; VENOUS THROMBOEMBOLISM;

HOSPITALISTS; HUMANS; INPATIENTS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; QUALITY ASSURANCE, HEALTH CARE;

EID: 39649119659     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2007.10.003     Document Type: Review

References (82)

1. DeFrances C.J., and Podgornik M.N. 2004 National hospital discharge survey. Advance data from vital and health statistics. National center for health statistics 371 (2006) 1-20
2. Devereaux P.J., Goldman L., Cook D.J., et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 173 6 (2005) 627-634
3. Foster E.D., Davis K.B., Carpenter J.A., et al. Risk of noncardiac operation in patients with defined coronary disease: The Coronary Artery Surgery Study (CASS) registry experience. Ann Thorac Surg 41 (1986) 42-50
4. Mahar L.J., Steen P.A., Tinker J.H., et al. Perioperative myocardial infarction in patients with coronary artery disease with and without aorta-coronary artery bypass grafts. J Thorac Cardiovasc Surg 76 (1978) 533-537
5. Nielsen J.L., Page C.P., Mann C., et al. Risk of major elective operation after myocardial revascularization. Am J Surg 164 (1992) 423-426
6. Gottlieb A., Banoub M., Sprung J., et al. Perioperative cardiovascular morbidity in patients with coronary artery disease undergoing vascular surgery after percutaneous transluminal coronary angioplasty. J Cardiothorac Vasc Anesth 12 (1998) 501-506
7. Hassan S.A., Hlatky M.A., Boothroyd D.B., et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the bypass angioplasty revascularization investigation (BARI). Am J Med 110 (2001) 260-266
8. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2002. American College of Cardiology Web site. Available at: http://www.acc.org/clinical/guidelines/perio/dirIndex.htm. Accessed October 18, 2007.
9. Reilly D.F., McNeely M.J., Doerner D., et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med 159 (1999) 2185-2192
10. Girish M., Trayner E., Dammann O., et al. Symptom-limited stair climbing as a predictor of postoperative cardiopulmonary complications after high-risk surgery. Chest 120 (2001) 1147-1151
11. Hlatky M.A., Boineau R.E., Higginbotham M.B., et al. A brief self-administered questionnaire to determine functional capacity (the Duke activity status index). Am J Cardiol 64 (1989) 651-654
12. Goldman L., Caldera D.L., Nussbaum S.R., et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297 (1977) 845-850
13. Detsky A.S., Abrams H.B., Forbath N., et al. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med 146 (1986) 2131-2134
14. Lee T.H., Marcantonio E.R., Mangione C.M., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 (1999) 1043-1049
15. Bottle A., and Aylin P. Mortality associated with delay in operation after hip fracture: observational study. BMJ 332 (2006) 947-950
16. McLaughlin M.A., Prosz G.M., Magaziner J., et al. Preoperative status and risk of complications in patients with hip fracture. J Gen Intern Med 21 (2006) 219-225
17. Pasternak L.R., Arens J.F., Caplan R.A., et al. Practice advisory for preanesthesia evaluation: a report by the American Society of Anesthesiologists Task Force on Preanesthesia evaluation. Anesthesiology 96 (2002) 485-496
18. Boersma E., Poldermans D., Bax J.J., et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and B-blocker therapy. JAMA 285 (2001) 1865-1873
19. Poldermans D., Bax J.J., Schouten O., et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. J Am Coll Cardiol 48 (2006) 964-969
20. Auerbach A., and Goldman L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation 113 (2006) 1361-1376
21. Wesorick D.H., and Eagle K.A. The preoperative cardiovascular evaluation of the intermediate-risk patient: new data, changing strategies. Am J Med 118 (2005) 1413
22. Grayburn P.A., and Hillis L.D. Cardiac events in patients undergoing noncardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med 138 (2003) 506-511
23. McFalls E.O., Ward H.B., Moritz T.E., et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351 (2004) 2795-2804
24. Kaluza G.L., Joseph J., Lee J.R., et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35 (2000) 1288-1294
25. Wilson S.H., Fasseas P., Orford J.L., et al. Clinical outcomes of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 42 (2003) 234-240
26. Sharma A.K., Ajani A.E., Hamwi S.M., et al. Major noncardiac surgery following coronary stenting: when is it safe to operate?. Catheter Cardiovasc Interv 63 (2004) 141-145
27. Reddy P.R., and Vaitkus P.T. Risks of noncardiac surgery after coronary stenting. Am J Cardiol 95 (2005) 755-757
28. Smith Jr SC, Feldman TE, Hirschfeld JW, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) American Heart Association Web Site. Available at: http://www.americanheart.org. Accessed October 18, 2007.
29. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
30. Eisenstein E.L., Anstrom K.J., Kong D.F., et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
31. Grines C.L., Bonow R.O., Casey D.E., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 49 (2007) 734-739
32. Burger W., Chemnitius J.M., Kneissl G.D., et al. Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J Intern Med 257 (2005) 399-414
33. Poldermans D., Boersma E., Bax J.J., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 3431 (1999) 1789-1794
34. Juul A.B., Wetterslev J., Gluud C., et al. Effect of perioperative beta blockade in patients with diabetes undergoing major noncardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 332 (2006) 1482
35. Mangano D.T., Layug E.L., Wallace A., et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335 (1996) 1713-1720
36. Brady A.R., Gibbs J.S., Greenhalgh R.M., et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41 (2005) 602-609
37. Devereaux P.J., Beattie W.S., Choi P.T.L., et al. How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 331 (2005) 313-321
38. Stevens R.D., Burri H., and Tramer M.R. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 97 (2003) 623-633
39. Lindenauer P.K., Pekow P., Wang K., et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 (2005) 349-361
40. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy. A report of the ACC/AHA task force on practice guidelines (Writing committee to update the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). J Am Coll Cardiol 47 (2006) 2343-2355
41. POISE Trial Investigators, Devereaux P.J., Yang H., et al. Rationale, design, and organization of the PeriOperative Ischemic Evaluation (POISE) Trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J 152 (2006) 223-230
42. Salpeter S.R., Ormiston T.M., and Salpeter E.E. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 136 (2002) 715-725
43. Salpeter S., Ormiston T., and Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 4 (2005) CD003566
44. Wijeysundera D.N., Naik J.S., and Beattie W.S. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 114 (2003) 742-752
45. Poldermans D., Bax J.J., Kertai M.D., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
46. Lindenauer P.K., Pekow P., Wang K., et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 291 (2004) 2092-2099
47. O'Neil-Callahan K., Katimaglis G., Tepper M.R., et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery. J Am Coll Cardiol 45 (2005) 336-342
48. McGirt M.J., Perler B.A., Brooke B.S., et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 42 (2005) 829-836
49. Ward R.P., Leeper N.J., Kirkpatrick J.N., et al. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol 104 (2005) 264-268
50. Durazzo A.E., Machado F.S., Ikeoka D.T., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 (2004) 967-976
51. Schouten O., Poldermans D., Visser L., et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: Rationale and design of the DECREASE-IV study. Am Heart J 148 (2004) 1047-1052
52. Fleischmann K.E., Goldman L., Young B., et al. Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: outcomes and effects on length of stay. Am J Med 115 (2003) 515-520
53. Lawrence V.A., Hilsenbeck S.G., Mulrow C.D., et al. Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery. J Gen Intern Med 10 (1995) 671-678
54. Qaseem A., Snow V., Fitterman N., et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med 144 (2006) 575-580
55. Smetana G.W., Lawrence V.A., and Cornell J.E. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 144 (2006) 581-595
56. Arozullah A.M., Daley J., and Henderson W.G. Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. The National Veterans Administration Surgical Quality Improvement Program. Ann Surg 232 (2000) 242-253
57. Arozullah A.M., Khuri S.F., Henderson W.G., et al. Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med 135 (2001) 847-857
58. Lawrence V.A., Dhanda R., Hilsenbeck S.G., et al. Risk of pulmonary complications after elective abdominal surgery. Chest 110 (1996) 744-750
59. Archer C., Levy A.R., and McGregor M. Value of routine preoperative chest x-rays: a meta-analysis. Can J Anaesth 40 (1993) 1022-1027
60. Smetana G.W., and Macpherson D.S. The case against routine preoperative laboratory testing. Med Clin North Am 87 (2003) 7-40
61. Kroenke K., Lawrence V.A., Theroux J.F., et al. Operative risk in patients with severe obstructive pulmonary disease. Arch Intern Med 152 (1992) 967-971
62. Pien L.C., Grammer L.C., and Patterson R. Minimal complications in a surgical population with severe asthma receiving prophylactic corticosteroids. J Allergy Clin Immunol 82 (1988) 696-700
63. Rodgers A., Walker N., Schug S., et al. Reduction of postoperative mortality and morbidity with epidural or spinal anesthesia: results from overview of randomised trials. BMJ 321 (2000) 1493
64. Thomas J.A., and McIntosh J.M. Are incentive spirometry, intermittent positive pressure breathing, and deep breathing exercises effective in the prevention of postoperative pulmonary complication after upper abdominal surgery? A systematic overview and meta-analysis. Phys Ther 74 (1994) 3-16
65. Ballantyne J.C., Carr D.B., deFerranti S., et al. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analysis of randomized, controlled trials. Anesth Analg 86 (1998) 598-612
66. Cheatham M.L., Chapman W.C., Key S.P., et al. A meta-analysis of selective versus routine nasogastric decompression after elective laparotomy. Ann Surg 221 (1995) 469-476
67. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126 Suppl 3 (2004) 338S-400S
68. Clagett G.P., and Reisch J.S. Prevention of venous thromboembolism in general surgical patients: results of meta-analysis. Ann Surg 208 (1988) 227-240
69. Kudsk K.A., Fabian T.C., Baum S., et al. Silent deep vein thrombosis in immobilized multiple trauma patients. Am J Surg 158 (1989) 515-519
70. Hefley Jr. F.G., Nelson C.L., and Puskarich-May C.L. Effect of delayed admission to the hospital on the preoperative prevalence of deep-vein thrombosis associated with fractures about the hip. J Bone Joint Surg Am 78 (1996) 581-583
71. Zahn H.R., Skinner J.A., and Porteous M.J. The preoperative prevalence of deep vein thrombosis in patients with femoral neck fractures and delayed operation. Injury 30 (1999) 605-607
72. Horlocker T.T., Wedel D.J., Benzon H., et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA consensus conference on neuraxial anesthesia and anticoagulation). Reg Anesth Pain Med 28 (2003) 172-197
73. Clement S., Baithwaite S.S., Magee M.F., et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27 (2004) 553-591
74. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001) 1359-1367
75. Pomposelli J.J., Baxter III J.K., Babineau T.J., et al. Early postoperative glucose control predicts nosocomial infection rates in diabetic patients. J Parenter Enter Nutr 22 (1998) 77-81
76. Furnary A.P., Zerr K.J., Grunkemeier G.L., et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 69 (2000) 667-668
77. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 985-987
78. The American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 29 Suppl 1 (2006) 4-9
79. Knecht L.A.D., Gauthier S.M., Castro J.C., et al. Diabetes care in the hospital: is there clinical inertia?. J Hosp Med 1 (2006) 151-160
80. Queale W.S., Seidler A.J., and Brancati F.L. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 157 (1997) 545-552
81. Inzucchi S.E. Management of hyperglycemia in the hospital setting. N Engl J Med 355 (2006) 1903-1911
82. Society of Hospital Medicine. The Society of Hospital Medicine Glycemic Control Resource Room. Available at: http://www.hospitalmedicine.org/AM/Template.cfm?Section=Quality_Improvem ent_Resource_Rooms&;Template=/CM/HTMLDisplay.cfm&ContentID=11585 . Accessed October 18, 2007.